In your state
Vermont

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: Vermont

$1.1B

Total output supported by biophamaceutical sector

$494,166

Total output supported by biophamaceutical sector

4,690

Total Jobs

1,157

Direct Jobs

Clinical Trials in Your State: Vermont

91

TOTAL CLINICAL TRIALS

$12.2 million

INVESTED IN CLINICAL TRIALS

1106

TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS

$30 million

INVESTED IN CLINICAL TRIALS

Programs and Initiatives in Your State: Vermont

State programs and initiatives to promote biopharmaceutical industry development

    ACCELERATING INNOVATION, COMMERCIALIZATION & ENTREPRENEURIAL DEVELOPMENT

    ECONOMIC INNOVATION INCENTIVES

    VENTURE FINANCING